Skip to main content
Sidley Life Sciences Briefing

Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech Companies

Switzerland is preparing to extend its integrity and anti-inducement rules to the medical device sector, significantly expanding compliance obligations for medtech companies operating in the Swiss market. The proposed revision would bring manufacturers, distributors, hospital procurement functions, and healthcare professionals within scope of a stricter regulatory framework governing commercial interactions involving medical devices.

Offices

Related Blogs